Get the Stockscreener App
6.69
1.04%
-0.07
After Hours:
6.80
0.11
+1.64%
Maravai Lifesciences Holdings Inc Stock (MRVI) Forecast
The Maravai Lifesciences Holdings Inc (MRVI) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.3697, representing a -64.58% decrease from the current price of $6.69. The highest analyst price target is $3.9827, and the lowest is $0.7567.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MRVI Price Target
Average 3.621
(-45.87% Downside)
Is Maravai Lifesciences Holdings Inc (MRVI) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 60.07 | Neutral |
| STOCH(9,6) | 65.27 | Neutral |
| STOCHRSI(14) | 3.0219 | Buy |
| MACD(12,26) | 0.4198 | Sell |
| ADX(14) | 51.34 | Buy |
| William %R | -42.37 | Neutral |
| CCI(14) | 14.30 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.957
Sell
|
6.802
Sell
|
| MA20 |
6.5195
Buy
|
6.5116
Buy
|
| MA50 |
5.5516
Buy
|
5.7172
Buy
|
| MA100 |
4.4977
Buy
|
4.9411
Buy
|
| MA200 |
3.9605
Buy
|
4.1457
Buy
|
Buy: 8
Sell: 2
Neutral: 0
Summary: Buy
According to our latest analysis, MRVI could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 3 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on MRVI, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 60.07 indicates that MRVI is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 65.27 indicates that MRVI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 3.0219 indicates that MRVI is oversold. This suggests that MRVI price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 51.34 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 14.3 indicates that MRVI is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term MRVI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Maravai Lifesciences Holdings Inc financial reports and earnings history, Maravai Lifesciences Holdings Inc (MRVI) stock could reach $4.3297 by 2030, $56.35 by 2040 and $60.37 by 2050. See the projected annual prices until 2050 of the Maravai Lifesciences Holdings Inc stock below:
- Maravai Lifesciences Holdings Inc (MRVI) is expected to reach an average price of $15.18 in 2035, with a high prediction of $15.22 and a low estimate of $14.97. This indicates an $126.87% rise from the last recorded price of $6.69.
- Maravai Lifesciences Holdings Inc (MRVI) stock is projected to chart a bullish course in 2040, with an average price target of $59.52, representing an $789.62% surge from its current level. The forecast ranges from a conservative $57.75 to a sky-high $56.35.
- Our analysts predict Maravai Lifesciences Holdings Inc (MRVI) to jump 617.23% by 2045, soaring from $51.85 to an average price of $47.98, potentially reaching $57.71. While $51.85 is the low estimate, the potential upside is significant.
- Maravai Lifesciences Holdings Inc (MRVI) stock is expected to climb by 2050, reaching an average of $59.91, a $795.56% jump from its current level. However, a wide range of estimates exists, with high and low targets of $60.37 and $60.68, respectively, highlighting the market's uncertainty.
Maravai Lifesciences Holdings Inc Stock (MRVI) Year by Year Forecast
Maravai Lifesciences Holdings Inc Stock (MRVI) Price Forecast for 2026
The predicted value for Maravai Lifesciences Holdings Inc (MRVI) in 2026 is set at an average of $10.56. Estimates vary from a peak of $20.36 to a trough of $0.7567, indicating an +57.81% surge from the present price of $6.69.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| August, 2026 | $2.6988 | $0.7567 | $3.9827 | -59.66% |
| September, 2026 | $3.5592 | $1.121 | $3.8192 | -46.80% |
| October, 2026 | $4.0235 | $3.0274 | $4.8663 | -39.86% |
| November, 2026 | $4.2478 | $2.9796 | $6.2896 | -36.51% |
| December, 2026 | $4.0281 | $3.0999 | $5.4139 | -39.79% |
Maravai Lifesciences Holdings Inc Stock (MRVI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Maravai Lifesciences Holdings Inc (MRVI) is $3.621, with a high forecast of $6.8685 and a low forecast of $0.3735. This indicates an -45.87% decrease from the last price of $6.69.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.0124 | $2.0724 | $5.1964 | -25.08% |
| February, 2027 | $3.7767 | $1.9707 | $6.8685 | -43.55% |
| March, 2027 | $2.9571 | $2.5121 | $5.4589 | -55.80% |
| April, 2027 | $2.3514 | $2.0903 | $4.1532 | -64.85% |
| May, 2027 | $1.7057 | $0.3735 | $3.2125 | -74.50% |
| June, 2027 | $1.2361 | $0.9261 | $2.7639 | -81.52% |
| July, 2027 | $1.1896 | $0.4157 | $1.9532 | -82.22% |
| August, 2027 | $2.7054 | $1.3764 | $1.1736 | -59.56% |
| September, 2027 | $2.385 | $2.49 | $2.2371 | -64.35% |
| October, 2027 | $0.7007 | $0.8118 | $0.8589 | -89.53% |
| November, 2027 | $1.1764 | $0.8746 | $0.6085 | -82.42% |
| December, 2027 | $1.084 | $1.009 | $2.194 | -83.80% |
Maravai Lifesciences Holdings Inc Stock (MRVI) Price Forecast for 2028
In 2028, Maravai Lifesciences Holdings Inc (MRVI) is projected to reach an average price of $15.33, with a high projection of $30.44 and a low estimate of $0.2258. This indicates an +129.16% rise from the last price of $6.69.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.3783 | $0.4461 | $2.4283 | -64.45% |
| February, 2028 | $1.1826 | $1.0726 | $2.6704 | -82.32% |
| March, 2028 | $13.14 | $1.2086 | $10.50 | +96.46% |
| April, 2028 | $11.44 | $9.4936 | $8.2993 | +70.99% |
| May, 2028 | $2.5685 | $3.2985 | $8.8071 | -61.61% |
| June, 2028 | $0.4999 | $2.1649 | $3.5579 | -92.53% |
| July, 2028 | $1.8514 | $1.3078 | $3.0822 | -72.33% |
| August, 2028 | $1.7894 | $0.3706 | $4.4894 | -73.25% |
| September, 2028 | $7.878 | $0.2258 | $8.408 | +17.76% |
| October, 2028 | $7.4266 | $6.072 | $11.22 | +11.01% |
| November, 2028 | $10.33 | $2.153 | $10.41 | +54.37% |
| December, 2028 | $26.46 | $9.6694 | $30.44 | +295.45% |
Maravai Lifesciences Holdings Inc Stock (MRVI) Price Forecast for 2029
The 2029 price forecast for Maravai Lifesciences Holdings Inc Stock (MRVI) is $14.50 on average, with a high prediction of $28.74 and a low estimate of $0.2554. This represents an +116.70% increase from the previous price of $6.69.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $16.90 | $11.69 | $28.74 | +152.57% |
| February, 2029 | $5.1552 | $4.8252 | $17.63 | -22.94% |
| March, 2029 | $6.2138 | $2.0916 | $14.90 | -7.12% |
| April, 2029 | $11.28 | $4.5081 | $15.29 | +68.65% |
| May, 2029 | $3.2431 | $1.7131 | $13.50 | -51.52% |
| June, 2029 | $0.7583 | $0.4847 | $4.6803 | -88.67% |
| July, 2029 | $7.9603 | $0.5403 | $10.70 | +18.99% |
| August, 2029 | $7.911 | $5.9467 | $13.20 | +18.25% |
| September, 2029 | $7.9896 | $4.9575 | $10.70 | +19.43% |
| October, 2029 | $6.2804 | $0.7339 | $8.3418 | -6.12% |
| November, 2029 | $1.2589 | $0.8689 | $8.6525 | -81.18% |
| December, 2029 | $3.1575 | $0.2554 | $3.1775 | -52.80% |
Maravai Lifesciences Holdings Inc Stock (MRVI) Price Forecast for 2030
Maravai Lifesciences Holdings Inc Stock (MRVI) is expected to reach an average price of $4.4642 in 2030, with a high forecast of $8.8667 and a low forecast of $0.0618. This signifies an -33.27% decrease from the last price of $6.69.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.2983 | $1.326 | $4.3297 | -80.59% |
| February, 2030 | $4.1831 | $0.3696 | $2.6131 | -37.47% |
| March, 2030 | $1.2954 | $2.0146 | $3.751 | -80.64% |
| April, 2030 | $7.316 | $0.0618 | $3.5381 | +9.36% |
| May, 2030 | $8.8652 | $7.1717 | $7.4752 | +32.51% |
| June, 2030 | $9.5267 | $9.1109 | $8.8667 | +42.40% |
| July, 2030 | $8.3159 | $8.9002 | $7.9959 | +24.30% |
| August, 2030 | $6.7373 | $6.9973 | $7.4838 | +0.71% |
| September, 2030 | $6.3387 | $6.9187 | $6.6602 | -5.25% |
| October, 2030 | $6.418 | $6.4344 | $6.093 | -4.07% |
| November, 2030 | $6.1094 | $6.2316 | $6.2409 | -8.68% |
| December, 2030 | $6.3208 | $6.6008 | $5.5108 | -5.52% |
1.97%
0.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):